Build Confidence in COVID-19 Boosters
COVID-19 vaccine hesitancy extends to recommended booster shots. People who completed a primary vaccination series may doubt the need for booster doses or question the efficacy of boosters, especially in light of confusing or conflicting media coverage. Some people no longer see COVID-19 as a threat or have grown weary of preventive measures, a phenomenon known as “pandemic fatigue.” Others balk at the prospect of repeated vaccination.
People ages 5 years and older are recommended to receive one bivalent mRNA booster dose after completing any monovalent primary series or previously receiving monovalent booster dose(s) as approved or authorized by the U.S. Food and Drug Administration (FDA). Centers for Disease Control and Prevention (CDC) recommendations for COVID-19 vaccines continue to evolve. This booster recommendation replaces all prior booster recommendations for this age group. Monovalent mRNA vaccines are no longer authorized as a booster dose for people 5 years of age and older.
A monovalent Novavax booster dose (instead of a bivalent mRNA booster dose) may be used in limited situations in people ages 18 years and older who completed any FDA-approved or FDA-authorized monovalent primary series, have not received any previous booster dose(s), and are unable (i.e., contraindicated or not available) or unwilling to receive an mRNA vaccine and would otherwise not receive a booster dose.
- It is normal for the protection provided by a vaccine, including COVID-19 vaccines, to decrease over time. This is not a sign that the vaccines don’t work.
- COVID-19 vaccine boosters can further enhance or restore protection against COVID-19 that may have decreased over time.
- COVID-19 vaccine boosters are essential for protecting against serious COVID-19 disease, including severe illness, hospitalization, and death.
- People are best protected from severe COVID-19 disease when they stay up to date with recommended COVID-19 vaccines, including getting all recommended boosters.
- Staying up to date with COVID-19 vaccines is crucial as new boosters are developed to improve protection against emerging virus variants.
Information for Pharmacy Teams
Participate in APhA’s Trigger Tape Training
, which reviews key points to communicate with patients by providing patient scenarios and the recommended response to each one.
Understand the issues and concerns associated with COVID-19 vaccine boosters among both patients and professionals:
Information for Patients